Effects of a Healthy Lifestyle Program on Health Outcomes in Older Adults

Sponsor
KU Leuven (Other)
Overall Status
Completed
CT.gov ID
NCT03576209
Collaborator
(none)
1,000
1
2
30
33.3

Study Details

Study Description

Brief Summary

Medical condition or disease under investigation : Quantitative and qualitative aspects of sleep, quality of life, functional ability and well-being in older adults (>55years)

Purpose of clinical trial : To study the prospective effects of a healthy lifestyle program on quantitative and qualitative aspects of sleep, quality of life, functional ability and well-being in older adults.

Primary objective : Measure the effects of the intervention on quantitative and qualitative aspects of sleep

Secondary objective (s) : Measure the effects of the intervention on physical activity, quality of life, functional ability and well-being Social identity and leadership, social support and motivation

Trial Design : Intervention study : controlled before-and-after study

Sample Size : total sample size : 1.000 participants

Summary of eligibility criteria : Older adults aged above 55years

Included in intervention group : adults who are participating in the healthy lifestyle promotion program 'Lekker Actief', organized by OKRA

Included in control group : waitlist controls or controls (adults, members of OKRA, not participating in the health promotion program 'Lekker Actief')

Maximum duration of treatment of a subject :
  • Start of Health promotion program 'Lekker Actief' : September 2018

  • Measurements with accelerometers will start prior to the health promotion program 'Lekker Actief' : July 2018

  • End of Health promotion program 'Lekker Actief' : December 2019

  • Duration of Health promotion program 'Lekker Actief': 12 weeks

  • Maximal duration : July 2018-December 2019

Condition or Disease Intervention/Treatment Phase
  • Behavioral: healthy lifestyle program
N/A

Detailed Description

This trial will consist of 3 visits : Pretest and posttest.

  • Pretest measurements (week 0)

o Accelerometry : a subsample of participants form intervention and control groups (n=400) will be asked to wear an accelerometer (type GT3X) during 7 entire days prior to baseline measurements. (Timing : July 2018-July 2019)

o Baseline measurements : during the start up moment of the program all participants from intervention and control groups will be asked : (Timing : July 2018-July 2019)

  • To fill out the self-reported questionnaire (survey) : the survey is composed of existing validated scales : IPAQ, PSQI, SF-12, WEMWBS, HAQ-DI. (references of validated scales are provided in the 'outcome measures' section)

  • To perform a walk test over 20 meters in order to determine the individual stride length

  • To perform a 6 minute walking test in order to self-report perceived exertion and physical fitness (by Borg Scale) and to determine the individual entry level of the program (entry levels vary between 1-12)

  • To wear the Pedometer (Omron® Walking Style one 2.0) on a daily basis and register the amount of daily steps in their personal registration forms

  • Posttest measurements (week 12)

  • Accelerometry : a subsample of participants form intervention and control groups (n=400) will be asked to wear an accelerometer (type GT3X®) during 7 days prior to posttest measurements. (Timing : September 2018 - December 2019)

  • Posttest measurements : at the end of the program all participants will be asked :

(Timing : September 2018 - December 2019)

  • To fill out the self-reported questionnaire (survey). In addition to the pretest questionnaire, the validated scales ILI, Mael and Ashford (1992) and BREQ-3 will be added and will be filled out only by participants of the intervention groups

  • To perform a 6 minute walking test in order to self-report perceived exertion and physical fitness (by Borg Scale)

  • To inform the investigators on the amount of daily steps (measured with pedometer type : Omron® Walking Style one 2.0) during the 12 week program o Focus groups : a subsample will be invited to take part in focus groups. During these focus groups, participants will be encouraged to discuss the program and possible effects in small groups (5 participants per group). A semi-structured interview guide will be used to guide the discussions.

Study Design

Study Type:
Interventional
Actual Enrollment :
1000 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The described trial is a controlled before-and-after study. In this study, observations are made before and after the implementation of the intervention during 12 weeks, both in groups participating in the program (intervention group) and in groups who are not participating in the program (control groups). Observations are made in intervention and control groups. Participants of the intervention group are registered for participation in this health promotion program 'Lekker Actief' prior to the start of this trial. The control groups are composed of participants who are not participating in the program (not receiving any intervention) or the controls are waitlist controls.The described trial is a controlled before-and-after study. In this study, observations are made before and after the implementation of the intervention during 12 weeks, both in groups participating in the program (intervention group) and in groups who are not participating in the program (control groups). Observations are made in intervention and control groups. Participants of the intervention group are registered for participation in this health promotion program 'Lekker Actief' prior to the start of this trial. The control groups are composed of participants who are not participating in the program (not receiving any intervention) or the controls are waitlist controls.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Prospective Study on Effects of a Healthy Lifestyle Program on Health Outcomes in Older Adults.
Actual Study Start Date :
Mar 1, 2018
Actual Primary Completion Date :
Jan 31, 2020
Actual Study Completion Date :
Aug 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intervention Group

12 week intervention

Behavioral: healthy lifestyle program
Participants (intervention group) are following a 12 week health promotion program. They will count daily steps by pedometers and participate in weekly organised walks (within socio-cultural organisation)
Other Names:
  • 12 week program 'Lekker Actief'
  • No Intervention: Control Group

    No walking program

    Outcome Measures

    Primary Outcome Measures

    1. Change in sleep [Pretest (week 0), posttest (week 12) and follow up (month 15)]

      Change in quantity of sleep : measured in minutes and hours by accelerometry and self-reported questionnaires (PSQI : Pittsburgh Sleep Quality Index (PSQI)) Change in quality of sleep : measured by self-reported questionnaire (PSQI)

    Secondary Outcome Measures

    1. Change in objectively perceived physical activity [Pretest (week 0), posttest (week 12) follow up (month 15)]

      Quantity : measured in minutes and hours by accelerometry

    2. Change in subjectively perceived physical activity [Pretest (week 0), posttest (week 12) follow up (month 15)]

      Quantity : measured by self-reported questionnaires (IPAQ : International Physical Activity Questionnaire)

    3. change in quality of life [Pretest (week 0), posttest (week 12) follow up (month 15)]

      measured by self-reported questionnaire (SF-12 : Short Form Health Survey)

    4. change in functional ability [Pretest (week 0), posttest (week 12) follow up (month 15)]

      measured by self-reported questionnaire (HAQ-DI : Health Assessment Questionnaire)

    5. change in wellbeing [Pretest (week 0), posttest (week 12) follow up (month 15)]

      well-being : measured by self-reported questionnaire (WEMWBS : Warwick-Edinburgh Mental Well-being scale)

    6. Social identity and leadership [Pretest (week 0), posttest (week 12)]

      measured by self-reported questionnaire (ILI : Identity Leadership Inventory)

    7. motivation [Pretest (week 0), posttest (week 12)]

      measured by self-reported questionnaire (BREQ3 : Behavioural Regulation In Exercise Questionnaire)

    8. Social support [Pretest (week 0), posttest (week 12)]

      measured by self-reported questionnaire (De Bourdeaudhuij & Salis, 2002)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    55 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    -aged 55+ years

    Exclusion Criteria:

    -Participants who are physically unable to participate in weekly meetings (PAR-Q : Physical activity readiness scale) (Thomas et al., 1992)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 KULeuven Leuven Flanders Belgium 3000

    Sponsors and Collaborators

    • KU Leuven

    Investigators

    • Principal Investigator: Julie Vanderlinden, phds, KU Leuven

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Julie Vanderlinden, Principal Investigator, KU Leuven
    ClinicalTrials.gov Identifier:
    NCT03576209
    Other Study ID Numbers:
    • Lekker Actief
    First Posted:
    Jul 3, 2018
    Last Update Posted:
    Jan 20, 2021
    Last Verified:
    Jan 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Julie Vanderlinden, Principal Investigator, KU Leuven

    Study Results

    No Results Posted as of Jan 20, 2021